Esperion Therapeutics
Stock Forecast, Prediction & Price Target
Esperion Therapeutics Financial Estimates
Esperion Therapeutics Revenue Estimates
Esperion Therapeutics EBITDA Estimates
Esperion Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $78.44M N/A | $75.47M -3.78% | $116.33M 54.13% | Avg: $419.66M Low: $419.66M High: $419.66M avg. 260.74% | Avg: $638.95M Low: $638.95M High: $638.95M avg. 52.25% | Avg: $868.7M Low: $868.7M High: $868.7M avg. 35.95% | Avg: $1.34B Low: $1.34B High: $1.34B avg. 54.50% |
Net Income
% change YoY
| $-318.82M N/A | $-287.81M 9.72% | $-209.24M 27.29% | Avg: $22.75M Low: $22.75M High: $22.75M avg. 110.87% | Avg: $103.77M Low: $103.77M High: $103.77M avg. 355.98% | Avg: $196.41M Low: $196.41M High: $196.41M avg. 89.28% | Avg: $359.84M Low: $359.84M High: $359.84M avg. 83.20% |
EBITDA
% change YoY
| $-222.75M N/A | $-176.84M 20.60% | $-150.10M 15.12% | Avg: $-346.76M Low: $-346.76M High: $-346.76M avg. -131.01% | Avg: $-527.95M Low: $-527.95M High: $-527.95M avg. -52.25% | Avg: $-717.79M Low: $-717.79M High: $-717.79M avg. -35.95% | Avg: $-1.10B Low: $-1.10B High: $-1.10B avg. -54.50% |
EPS
% change YoY
| -$11.03 N/A | -$4.33 60.74% | -$2.03 53.11% | Avg: $0.22 Low: $0.22 High: $0.22 avg. 110.87% | Avg: $1.01 Low: $1.01 High: $1.01 avg. 355.98% | Avg: $1.91 Low: $1.91 High: $1.91 avg. 89.28% | Avg: $3.49 Low: $3.49 High: $3.49 avg. 83.20% |
Operating Expenses
% change YoY
| $290.96M N/A | $228.00M -21.63% | $228.63M 0.27% | Avg: $532.82M Low: $532.82M High: $532.82M avg. 133.05% | Avg: $811.23M Low: $811.23M High: $811.23M avg. 52.25% | Avg: $1.10B Low: $1.10B High: $1.10B avg. 35.95% | Avg: $1.70B Low: $1.70B High: $1.70B avg. 54.50% |
FAQ
What is Esperion Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 159.83% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is 22.75M, average is 22.75M and high is 22.75M.
What is Esperion Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 100.86% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $419.66M, average is $419.66M and high is $419.66M.
What is Esperion Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 159.83% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is $0.22, average is $0.22 and high is $0.22.